{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T08:38:52Z","timestamp":1783845532067,"version":"3.55.0"},"reference-count":223,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01588-0","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T07:46:19Z","timestamp":1741247179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1029-751X","authenticated-orcid":false,"given":"Atieh","family":"Raoufi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-7613","authenticated-orcid":false,"given":"Hamed","family":"Soleimani Samarkhazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4863-2595","authenticated-orcid":false,"given":"Sina","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-0007","authenticated-orcid":false,"given":"Mohammad Navid","family":"Khaksari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4164-9226","authenticated-orcid":false,"given":"Parvaneh","family":"Abbasi Sourki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-5125","authenticated-orcid":false,"given":"Omolbanin","family":"Sargazi Aval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-6795","authenticated-orcid":false,"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6382-6657","authenticated-orcid":false,"given":"Mojtaba","family":"Aghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"issue":"3","key":"1588_CR1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/bjh.15719","volume":"184","author":"X Li","year":"2019","unstructured":"Li X, Gao Q, Feng Y, Zhang X. Developing role of B cells in the pathogenesis and treatment of chronic GVHD. Br J Haematol. 2019;184(3):323\u201336.","journal-title":"Br J Haematol"},{"key":"1588_CR2","doi-asserted-by":"crossref","first-page":"578314","DOI":"10.3389\/fimmu.2020.578314","volume":"11","author":"NEB Saidu","year":"2020","unstructured":"Saidu NEB, Bonini C, Dickinson A, Grce M, Inngjerdingen M, Koehl U, et al. New approaches for the treatment of chronic graft-versus-host disease: current status and future directions. Front Immunol. 2020;11:578314.","journal-title":"Front Immunol"},{"key":"1588_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/164_2021_544","volume":"272","author":"TF Michniacki","year":"2022","unstructured":"Michniacki TF, Choi SW, Peltier DC. Immune suppression in allogeneic hematopoietic stem cell transplantation. Handb Exp Pharmacol. 2022;272:209\u201343.","journal-title":"Handb Exp Pharmacol"},{"issue":"8","key":"1588_CR4","doi-asserted-by":"crossref","first-page":"e70008","DOI":"10.1002\/hsr2.70008","volume":"7","author":"M Aghaei","year":"2024","unstructured":"Aghaei M, Khademi R, Bahreiny SS, Saki N. The need to establish and recognize the field of clinical laboratory science (CLS) as an essential field in advancing clinical goals. Health Sci Rep. 2024;7(8):e70008.","journal-title":"Health Sci Rep"},{"key":"1588_CR5","doi-asserted-by":"crossref","first-page":"5385972","DOI":"10.1155\/2016\/5385972","volume":"2016","author":"LF Porrata","year":"2016","unstructured":"Porrata LF. Autologous graft-versus-tumor effect: reality or fiction? Adv Hematol. 2016;2016:5385972.","journal-title":"Adv Hematol"},{"issue":"4","key":"1588_CR6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.2019004271","volume":"136","author":"R Zeiser","year":"2020","unstructured":"Zeiser R. Introduction to a review series on pathophysiology and treatment of acute GVHD. Blood. 2020;136(4):375\u20136.","journal-title":"Blood"},{"key":"1588_CR7","doi-asserted-by":"crossref","first-page":"1079708","DOI":"10.3389\/fimmu.2022.1079708","volume":"13","author":"G Socie","year":"2022","unstructured":"Socie G, Michonneau D. Milestones in acute GVHD pathophysiology. Front Immunol. 2022;13:1079708.","journal-title":"Front Immunol"},{"key":"1588_CR8","doi-asserted-by":"crossref","first-page":"715424","DOI":"10.3389\/fimmu.2021.715424","volume":"12","author":"T Teshima","year":"2021","unstructured":"Teshima T, Hill GR. The pathophysiology and treatment of graft-versus-host disease: lessons learnt from animal models. Front Immunol. 2021;12:715424.","journal-title":"Front Immunol"},{"key":"1588_CR9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2017.00079","volume":"8","author":"S Ghimire","year":"2017","unstructured":"Ghimire S, Weber D, Mavin E, Wang XN, Dickinson AM, Holler E. Pathophysiology of GVHD and other HSCT-related major complications. Front Immunol. 2017;8:79.","journal-title":"Front Immunol"},{"issue":"3","key":"1588_CR10","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/cam4.5209","volume":"12","author":"J Yu","year":"2023","unstructured":"Yu J, Hamilton BK, Turnbull J, Stewart SK, Vernaya A, Bhatt V, et al. Patient-reported symptom burden and impact on daily activities in chronic graft-versus-host disease. Cancer Med. 2023;12(3):3623\u201333.","journal-title":"Cancer Med"},{"issue":"10","key":"1588_CR11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/17474086.2020.1818065","volume":"13","author":"M Csan\u00e1di","year":"2020","unstructured":"Csan\u00e1di M, \u00c1gh T, Farkas-R\u00e1duly S, Gros B, Tapprich C, Trudeau JJ, et al. Patient-reported symptom burden of chronic graft versus host disease: a systematic literature review. Expert Rev Hematol. 2020;13(10):1119\u201330.","journal-title":"Expert Rev Hematol"},{"issue":"9","key":"1588_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1182\/blood.2024025106","volume":"144","author":"Yu Akahoshi","year":"2024","unstructured":"Akahoshi Yu, Spyrou N, Weber D, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, Eder M, Etra AM, Grupp SA, Hexner EO, Hogan WJ, Kitko CL, Kraus S, Al MM, Malki PM, Qayed M, Reshef R, Schechter T, Ullrich E, Vasova I, W\u00f6lfl M, Zeiser R, Baez J, Beheshti R, Eng G, Gleich S, Katsivelos N, Kowalyk S, Morales G, Young R, Chen Y-B, Nakamura R, Levine JE, Ferrara JLM. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD. Blood. 2024;144(9):1010\u201321. https:\/\/doi.org\/10.1182\/blood.2024025106.","journal-title":"Blood"},{"issue":"1","key":"1588_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","volume":"9","author":"F Malard","year":"2023","unstructured":"Malard F, Holler E, Sandmaier BM, Huang H, Mohty M. Acute graft-versus-host disease. Nat Rev Dis Primers. 2023;9(1):27.","journal-title":"Nat Rev Dis Primers"},{"key":"1588_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.coi.2017.12.001","volume":"50","author":"J Bonnardel","year":"2018","unstructured":"Bonnardel J, Guilliams M. Developmental control of macrophage function. Curr Opin Immunol. 2018;50:64\u201374.","journal-title":"Curr Opin Immunol"},{"key":"1588_CR15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.actbio.2021.03.038","volume":"133","author":"KE Martin","year":"2021","unstructured":"Martin KE, Garc\u00eda AJ. Macrophage phenotypes in tissue repair and the foreign body response: implications for biomaterial-based regenerative medicine strategies. Acta Biomater. 2021;133:4\u201316.","journal-title":"Acta Biomater"},{"issue":"2","key":"1588_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/cells10020436","volume":"10","author":"P Cheng","year":"2021","unstructured":"Cheng P, Li S, Chen H. Macrophages in lung injury, repair, and fibrosis. Cells. 2021;10(2):436. https:\/\/doi.org\/10.3390\/cells10020436.","journal-title":"Cells"},{"issue":"11","key":"1588_CR17","doi-asserted-by":"crossref","first-page":"e70191","DOI":"10.1002\/hsr2.70191","volume":"7","author":"M Torabizadeh","year":"2024","unstructured":"Torabizadeh M, Aghaei M, Saki N, Vahid MA, Bitaraf S, Bandar B. The association of nasal and blood eosinophils with serum IgE level in allergic rhinitis and asthma: a case-control study. Health Sci Rep. 2024;7(11):e70191.","journal-title":"Health Sci Rep"},{"issue":"10","key":"1588_CR18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.12998\/wjcc.v8.i10.1793","volume":"8","author":"YQ Hong","year":"2020","unstructured":"Hong YQ, Wan B, Li XF. Macrophage regulation of graft-vs-host disease. World J Clin Cases. 2020;8(10):1793\u2013805.","journal-title":"World J Clin Cases"},{"issue":"2","key":"1588_CR19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.61186\/ijbc.16.2.84","volume":"16","author":"SA Aghapour","year":"2024","unstructured":"Aghapour SA, Torabizadeh M, Bahreiny SS, Saki N, Jalali Far MA, Yousefi-Avarvand A, et al. Investigating the dynamic interplay between cellular immunity and tumor cells in the fight against cancer: an updated comprehensive review. Iran J Blood Cancer. 2024;16(2):84\u2013101.","journal-title":"Iran J Blood Cancer"},{"issue":"7446","key":"1588_CR20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496(7446):445\u201355.","journal-title":"Nature"},{"issue":"12","key":"1588_CR21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nri3920","volume":"15","author":"Y Lavin","year":"2015","unstructured":"Lavin Y, Mortha A, Rahman A, Merad M. Regulation of macrophage development and function in peripheral tissues. Nat Rev Immunol. 2015;15(12):731\u201344.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1588_CR22","doi-asserted-by":"crossref","first-page":"e70083","DOI":"10.1002\/hsr2.70083","volume":"7","author":"E Torfi","year":"2024","unstructured":"Torfi E, Bahreiny SS, Saki N, Khademi R, Sarbazjoda E, Nezhad IA, et al. Evaluation of Pro-BNP biomarker in heart failure patients and its relationship with complete blood count parameters: a case\u2013control study. Health Sci Rep. 2024;7(9):e70083.","journal-title":"Health Sci Rep"},{"issue":"5","key":"1588_CR23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jid.2020.09.018","volume":"141","author":"N Kubota","year":"2021","unstructured":"Kubota N, Saito A, Tanaka R, Nakamura Y, Watanabe R, Fujisawa Y, et al. Langerhans cells suppress CD8(+) T cells in situ during mucocutaneous acute graft-versus-host disease. J Invest Dermatol. 2021;141(5):1177\u201387.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1588_CR24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41423-019-0226-0","volume":"17","author":"Z Chu","year":"2020","unstructured":"Chu Z, Sun C, Sun L, Feng C, Yang F, Xu Y, et al. Primed macrophages directly and specifically reject allografts. Cell Mol Immunol. 2020;17(3):237\u201346.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"1588_CR25","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/iid3.503","volume":"9","author":"R Hanaki","year":"2021","unstructured":"Hanaki R, Toyoda H, Iwamoto S, Morimoto M, Nakato D, Ito T, et al. Donor-derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation. Immun Inflamm Dis. 2021;9(4):1489\u201399.","journal-title":"Immun Inflamm Dis"},{"issue":"3","key":"1588_CR26","first-page":"344","volume":"124","author":"B Gyurkocza","year":"2014","unstructured":"Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. J Am Soc Hematol. 2014;124(3):344\u201353.","journal-title":"J Am Soc Hematol"},{"issue":"11","key":"1588_CR27","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2013-05-355982","volume":"122","author":"EW Petersdorf","year":"2013","unstructured":"Petersdorf EW. The major histocompatibility complex: a model for understanding graft-versus-host disease. Blood. 2013;122(11):1863\u201372.","journal-title":"Blood"},{"issue":"3","key":"1588_CR28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2014-02-514745","volume":"124","author":"KA Markey","year":"2014","unstructured":"Markey KA, MacDonald KP, Hill GR. The biology of graft-versus-host disease: experimental systems instructing clinical practice. Blood. 2014;124(3):354\u201362.","journal-title":"Blood"},{"issue":"7","key":"1588_CR29","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1172\/JCI90593","volume":"127","author":"KP MacDonald","year":"2017","unstructured":"MacDonald KP, Blazar BR, Hill GR. Cytokine mediators of chronic graft-versus-host disease. J Clin Investig. 2017;127(7):2452\u201363.","journal-title":"J Clin Investig"},{"issue":"24","key":"1588_CR30","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2017-11-785865","volume":"131","author":"BR Blazar","year":"2018","unstructured":"Blazar BR, MacDonald KPA, Hill GR. Immune regulatory cell infusion for graft-versus-host disease prevention and therapy. Blood. 2018;131(24):2651\u201360.","journal-title":"Blood"},{"issue":"3","key":"1588_CR31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Investig. 2012;122(3):787\u201395.","journal-title":"J Clin Investig"},{"issue":"1","key":"1588_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-023-00360-z","volume":"20","author":"T Xia","year":"2023","unstructured":"Xia T, Fu S, Yang R, Yang K, Lei W, Yang Y, et al. Advances in the study of macrophage polarization in inflammatory immune skin diseases. J Inflamm (Lond). 2023;20(1):33.","journal-title":"J Inflamm (Lond)"},{"issue":"5","key":"1588_CR33","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2016.08.017","volume":"166","author":"S Gordon","year":"2016","unstructured":"Gordon S. Phagocytosis: the legacy of Metchnikoff. Cell. 2016;166(5):1065\u20138.","journal-title":"Cell"},{"issue":"12","key":"1588_CR34","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1\/M-2 macrophages and the Th1\/Th2 paradigm. J Immunol. 2000;164(12):6166\u201373.","journal-title":"J Immunol"},{"issue":"1","key":"1588_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray PJ. Macrophage polarization. Annu Rev Physiol. 2017;79(1):541\u201366. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034339.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"1588_CR36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14\u201320.","journal-title":"Immunity"},{"issue":"1\u20133","key":"1588_CR37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12026-012-8291-9","volume":"53","author":"SK Biswas","year":"2012","unstructured":"Biswas SK, Chittezhath M, Shalova IN, Lim JY. Macrophage polarization and plasticity in health and disease. Immunol Res. 2012;53(1\u20133):11\u201324.","journal-title":"Immunol Res"},{"key":"1588_CR38","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1100\/2011\/213962","volume":"11","author":"L Cassetta","year":"2011","unstructured":"Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. Sci World J. 2011;11:2391\u2013402.","journal-title":"Sci World J"},{"issue":"21","key":"1588_CR39","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1007\/s00018-015-1995-y","volume":"72","author":"A Sica","year":"2015","unstructured":"Sica A, Erreni M, Allavena P, Porta C. Macrophage polarization in pathology. Cell Mol Life Sci. 2015;72(21):4111\u201326.","journal-title":"Cell Mol Life Sci"},{"key":"1588_CR40","first-page":"1","volume":"1","author":"V Kumar","year":"2019","unstructured":"Kumar V. Macrophages: the potent immunoregulatory innate immune cells. Macrophage Act Biol Dis. 2019;1:1\u201330.","journal-title":"Macrophage Act Biol Dis"},{"issue":"5","key":"1588_CR41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jre.12912","volume":"56","author":"B Zhang","year":"2021","unstructured":"Zhang B, Yang Y, Yi J, Zhao Z, Ye R. Hyperglycemia modulates M1\/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis. J Periodontal Res. 2021;56(5):991\u20131005.","journal-title":"J Periodontal Res"},{"issue":"10","key":"1588_CR42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/17474086.2024.2391102","volume":"17","author":"Z Eftekhar","year":"2024","unstructured":"Eftekhar Z, Aghaei M, Saki N. DNA damage repair in megakaryopoiesis: molecular and clinical aspects. Expert Rev Hematol. 2024;17(10):705\u201312.","journal-title":"Expert Rev Hematol"},{"issue":"19","key":"1588_CR43","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.3390\/cells11192953","volume":"11","author":"A Hassanshahi","year":"2022","unstructured":"Hassanshahi A, Moradzad M, Ghalamkari S, Fadaei M, Cowin AJ, Hassanshahi M. Macrophage-mediated inflammation in skin wound healing. Cells. 2022;11(19):2953. https:\/\/doi.org\/10.3390\/cells11192953.","journal-title":"Cells"},{"issue":"9","key":"1588_CR44","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri\u2010Moghaddam","year":"2018","unstructured":"Shapouri\u2010Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili S-A, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425\u201340. https:\/\/doi.org\/10.1002\/jcp.26429.","journal-title":"J Cell Physiol"},{"key":"1588_CR45","doi-asserted-by":"crossref","first-page":"116930","DOI":"10.1016\/j.biopha.2024.116930","volume":"177","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Ji C, Liu X, Gu B, Dong T. Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials. Biomed Pharmacother. 2024;177:116930.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"1588_CR46","doi-asserted-by":"crossref","first-page":"e658","DOI":"10.1002\/mco2.658","volume":"5","author":"L Yan","year":"2024","unstructured":"Yan L, Wang J, Cai X, Liou YC, Shen HM, Hao J, et al. Macrophage plasticity: signaling pathways, tissue repair, and regeneration. MedComm. 2024;5(8):e658.","journal-title":"MedComm"},{"key":"1588_CR47","first-page":"614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1\u2013m2 polarization balance. Front Immunol. 2014;5:614.","journal-title":"Front Immunol"},{"key":"1588_CR48","doi-asserted-by":"crossref","first-page":"1173899","DOI":"10.3389\/fcimb.2023.1173899","volume":"13","author":"X Fan","year":"2023","unstructured":"Fan X, Zheng S, Chen C, Lin L, Wang H, Shen Y, et al. Sialidase facilitates Porphyromonas gingivalis immune evasion by reducing M1 polarization, antigen presentation, and phagocytosis of infected macrophages. Front Cell Infect Microbiol. 2023;13:1173899.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"1588_CR49","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.bbrc.2020.10.062","volume":"533","author":"L Li","year":"2020","unstructured":"Li L, Wei C, Cai S, Fang L. TRPM7 modulates macrophage polarization by STAT1\/STAT6 pathways in RAW264.7\u00a0cells. Biochem Biophys Res Commun. 2020;533(4):692\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.062.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1588_CR50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cellsig.2013.11.004","volume":"26","author":"D Zhou","year":"2014","unstructured":"Zhou D, Huang C, Lin Z, Zhan S, Kong L, Fang C, et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal. 2014;26(2):192\u20137.","journal-title":"Cell Signal"},{"issue":"4","key":"1588_CR51","doi-asserted-by":"crossref","first-page":"C762","DOI":"10.1152\/ajpcell.00212.2019","volume":"317","author":"Y Liu","year":"2019","unstructured":"Liu Y, Liu Z, Tang H, Shen Y, Gong Z, Xie N, et al. The <i>N<\/i><sup>6<\/sup>-methyladenosine (m<sup>6<\/sup>A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of <i>STAT1<\/i> mRNA. Am J Physiol Cell Physiol. 2019;317(4):C762\u201375.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1588_CR52","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.3c05597","author":"L Wang","year":"2024","unstructured":"Wang L, Wang J, Han L, Chen T. Palmatine attenuated lipopolysaccharide-induced acute lung injury by inhibiting M1 phenotype macrophage polarization via NAMPT\/TLR2\/CCR1 signaling. J Agric Food Chem. 2024. https:\/\/doi.org\/10.1021\/acs.jafc.3c05597.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"1588_CR53","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1038\/s41467-023-40635-w","volume":"14","author":"CU Onyishi","year":"2023","unstructured":"Onyishi CU, Desanti GE, Wilkinson AL, Lara-Reyna S, Frickel EM, Fejer G, et al. Toll-like receptor 4 and macrophage scavenger receptor 1 crosstalk regulates phagocytosis of a fungal pathogen. Nat Commun. 2023;14(1):4895.","journal-title":"Nat Commun"},{"key":"1588_CR54","doi-asserted-by":"crossref","first-page":"1044662","DOI":"10.3389\/fimmu.2022.1044662","volume":"13","author":"AM Owen","year":"2022","unstructured":"Owen AM, Luan L, Burelbach KR, McBride MA, Stothers CL, Boykin OA, et al. MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages. Front Immunol. 2022;13:1044662.","journal-title":"Front Immunol"},{"issue":"7","key":"1588_CR55","doi-asserted-by":"crossref","first-page":"111225","DOI":"10.1016\/j.celrep.2022.111225","volume":"40","author":"M Pereira","year":"2022","unstructured":"Pereira M, Durso DF, Bryant CE, Kurt-Jones EA, Silverman N, Golenbock DT, et al. The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways. Cell Rep. 2022;40(7):111225.","journal-title":"Cell Rep"},{"key":"1588_CR56","doi-asserted-by":"crossref","first-page":"120064","DOI":"10.1016\/j.lfs.2021.120064","volume":"291","author":"X Luo","year":"2022","unstructured":"Luo X, Bao X, Weng X, Bai X, Feng Y, Huang J, et al. The protective effect of quercetin on macrophage pyroptosis via TLR2\/Myd88\/NF-\u03baB and ROS\/AMPK pathway. Life Sci. 2022;291:120064.","journal-title":"Life Sci"},{"key":"1588_CR57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4939-7837-3_12","volume":"1784","author":"X Huang","year":"2018","unstructured":"Huang X, Li Y, Fu M, Xin HB. Polarizing macrophages in vitro. Methods Mol Biol. 2018;1784:119\u201326.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"1588_CR58","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1172\/JCI128644","volume":"129","author":"AJ Petty","year":"2019","unstructured":"Petty AJ, Li A, Wang X, Dai R, Heyman B, Hsu D, et al. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment. J Clin Investig. 2019;129(12):5151\u201362.","journal-title":"J Clin Investig"},{"issue":"1","key":"1588_CR59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40168-022-01227-w","volume":"10","author":"J Hu","year":"2022","unstructured":"Hu J, Deng F, Zhao B, Lin Z, Sun Q, Yang X, et al. Lactobacillus murinus alleviate intestinal ischemia\/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via Toll-like receptor 2 signaling. Microbiome. 2022;10(1):38.","journal-title":"Microbiome"},{"key":"1588_CR60","first-page":"8326591","volume":"2022","author":"XH Fu","year":"2022","unstructured":"Fu XH, Li JP, Li XY, Tan Y, Zhao M, Zhang SF, et al. M2-macrophage-derived exosomes promote meningioma progression through TGF-\u03b2 signaling pathway. J Immunol Res. 2022;2022:8326591.","journal-title":"J Immunol Res"},{"issue":"9","key":"1588_CR61","doi-asserted-by":"crossref","first-page":"e13440","DOI":"10.1111\/cpr.13440","volume":"56","author":"G Cai","year":"2023","unstructured":"Cai G, Lu Y, Zhong W, Wang T, Li Y, Ruan X, et al. Piezo1-mediated M2 macrophage mechanotransduction enhances bone formation through secretion and activation of transforming growth factor-\u03b21. Cell Prolif. 2023;56(9):e13440.","journal-title":"Cell Prolif"},{"key":"1588_CR62","doi-asserted-by":"crossref","first-page":"807228","DOI":"10.3389\/fmolb.2022.807228","volume":"9","author":"MA Ordaz-Arias","year":"2022","unstructured":"Ordaz-Arias MA, Diaz-Alvarez L, Zuniga J, Martinez-Sanchez ME, Balderas-Martinez YI. Cyclic attractors are critical for macrophage differentiation, heterogeneity, and plasticity. Front Mol Biosci. 2022;9:807228.","journal-title":"Front Mol Biosci"},{"issue":"2","key":"1588_CR63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/TP.0000000000003804","volume":"106","author":"SE Panzer","year":"2022","unstructured":"Panzer SE. Macrophages in transplantation: a matter of plasticity, polarization, and diversity. Transplantation. 2022;106(2):257\u201367.","journal-title":"Transplantation"},{"issue":"2","key":"1588_CR64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","volume":"106","author":"LX Wang","year":"2019","unstructured":"Wang LX, Zhang SX, Wu HJ, Rong XL, Guo J. M2b macrophage polarization and its roles in diseases. J Leukoc Biol. 2019;106(2):345\u201358.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"1588_CR65","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.4049\/jimmunol.1200662","volume":"189","author":"G Zizzo","year":"2012","unstructured":"Zizzo G, Hilliard BA, Monestier M, Cohen PL. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol. 2012;189(7):3508\u201320.","journal-title":"J Immunol"},{"issue":"1","key":"1588_CR66","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11033-024-10200-9","volume":"52","author":"L Rajabi","year":"2025","unstructured":"Rajabi L, Ebrahimdoost M, Mohammadi SA, Soleimani Samarkhazan H, Khamisipour G, Aghaei M. Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53. Mol Biol Rep. 2025;52(1):102.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"1588_CR67","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/JLB.6A1120-744R","volume":"111","author":"CB Anders","year":"2022","unstructured":"Anders CB, Lawton TMW, Smith HL, Garret J, Doucette MM, Ammons MCB. Use of integrated metabolomics, transcriptomics, and signal protein profile to characterize the effector function and associated metabotype of polarized macrophage phenotypes. J Leukoc Biol. 2022;111(3):667\u201393.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"1588_CR68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1189\/jlb.5MA1116-457R","volume":"102","author":"M Roussel","year":"2017","unstructured":"Roussel M, Ferrell PB Jr, Greenplate AR, Lhomme F, Le Gallou S, Diggins KE, et al. Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow. J Leukoc Biol. 2017;102(2):437\u201347.","journal-title":"J Leukoc Biol"},{"key":"1588_CR69","doi-asserted-by":"crossref","first-page":"1139137","DOI":"10.3389\/fphar.2023.1139137","volume":"14","author":"P Fan","year":"2023","unstructured":"Fan P, Zhang Y, Ding S, Du Z, Zhou C, Du X. Integrating RNA-seq and scRNA-seq to explore the mechanism of macrophage ferroptosis associated with COPD. Front Pharmacol. 2023;14:1139137.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1588_CR70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8(1):207.","journal-title":"Signal Transduct Target Ther"},{"key":"1588_CR71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.","journal-title":"F1000Prime Rep"},{"issue":"10","key":"1588_CR72","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889\u201396.","journal-title":"Nat Immunol"},{"issue":"5","key":"1588_CR73","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/tropicalmed8050276","volume":"8","author":"FS Almeida","year":"2023","unstructured":"Almeida FS, Vanderley SER, Comberlang FC, Gomes A, de Andrade L, Cavalcante-Silva HA, dos Santos E, Silva PH, et al. Leishmaniasis: immune cells crosstalk in macrophage polarization. Trop Med Infect Dis. 2023;8(5):276. https:\/\/doi.org\/10.3390\/tropicalmed8050276.","journal-title":"Trop Med Infect Dis"},{"key":"1588_CR74","doi-asserted-by":"crossref","first-page":"113463","DOI":"10.1016\/j.intimp.2024.113463","volume":"143","author":"Y Su","year":"2024","unstructured":"Su Y, Liu S, Long C, Zhou Z, Zhou Y, Tang J. The cross-talk between B cells and macrophages. Int Immunopharmacol. 2024;143:113463.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1588_CR75","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1111\/jcmm.14232","volume":"23","author":"Z Wu","year":"2019","unstructured":"Wu Z, Xu J, Tan J, Song Y, Liu L, Zhang F, et al. Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice. J Cell Mol Med. 2019;23(5):3375\u201385.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1588_CR76","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.immuni.2022.03.020","volume":"55","author":"S Jiang","year":"2022","unstructured":"Jiang S, Chan CN, Rovira-Clav\u00e9 X, Chen H, Bai Y, Zhu B, et al. Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironments. Immunity. 2022;55(6):1118-34.e8.","journal-title":"Immunity"},{"issue":"11","key":"1588_CR77","doi-asserted-by":"crossref","first-page":"e0256651","DOI":"10.1371\/journal.pone.0256651","volume":"16","author":"H-W Jang","year":"2021","unstructured":"Jang H-W, An J-H, Kim KB, Lee J-H, Oh Y-I, Park S-M, et al. Canine peripheral blood mononuclear cell-derived B lymphocytes pretreated with lipopolysaccharide enhance the immunomodulatory effect through macrophage polarization. PLoS ONE. 2021;16(11):e0256651.","journal-title":"PLoS ONE"},{"issue":"11","key":"1588_CR78","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/jcmm.17748","volume":"27","author":"J-H Huang","year":"2023","unstructured":"Huang J-H, Lin Y-L, Wang L-C, Chiang B-L. M2-like macrophages polarized by Foxp3\u2212 Treg-of-B cells ameliorate imiquimod-induced psoriasis. J Cell Mol Med. 2023;27(11):1477\u201392.","journal-title":"J Cell Mol Med"},{"key":"1588_CR79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.archoralbio.2019.03.029","volume":"102","author":"AI Lorenzo-Pouso","year":"2019","unstructured":"Lorenzo-Pouso AI, Castelo-Baz P, P\u00e9rez-Say\u00e1ns M, Lim J, Leira Y. Autophagy in periodontal disease: evidence from a literature review. Arch Oral Biol. 2019;102:55\u201364.","journal-title":"Arch Oral Biol"},{"issue":"5","key":"1588_CR80","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3892\/ijmm.2013.1311","volume":"31","author":"P Thulin","year":"2013","unstructured":"Thulin P, Wei T, Werngren O, Cheung L, Fisher RM, Grand\u00e9r D, et al. MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor \u03b4 in human monocytes during the inflammatory response. Int J Mol Med. 2013;31(5):1003\u201310.","journal-title":"Int J Mol Med"},{"issue":"10","key":"1588_CR81","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.4049\/jimmunol.1102001","volume":"187","author":"AA Chaudhuri","year":"2011","unstructured":"Chaudhuri AA, So A-L, Sinha N, Gibson WSJ, Taganov KD, O\u2019Connell RM, Baltimore D. MicroRNA-125b potentiates macrophage activation. J Immunol. 2011;187(10):5062\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1102001.","journal-title":"J Immunol"},{"issue":"6","key":"1588_CR82","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3748\/wjg.v23.i6.976","volume":"23","author":"ZJ Lu","year":"2017","unstructured":"Lu ZJ, Wu JJ, Jiang WL, Xiao JH, Tao KZ, Ma L, et al. MicroRNA-155 promotes the pathogenesis of experimental colitis by repressing SHIP-1 expression. World J Gastroenterol. 2017;23(6):976\u201385.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1588_CR83","first-page":"8060182","volume":"2016","author":"J Ye","year":"2016","unstructured":"Ye J, Guo R, Shi Y, Qi F, Guo C, Yang L. miR-155 regulated inflammation response by the SOCS1-STAT3-PDCD4 axis in atherogenesis. Mediat Inflamm. 2016;2016(1):8060182.","journal-title":"Mediat Inflamm"},{"issue":"5","key":"1588_CR84","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/cmi.2009.45","volume":"6","author":"M He","year":"2009","unstructured":"He M, Xu Z, Ding T, Kuang D-M, Zheng L. MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C\/EBP\u03b2. Cell Mol Immunol. 2009;6(5):343\u201352.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"1588_CR85","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/cr.2013.116","volume":"23","author":"Y Sun","year":"2013","unstructured":"Sun Y, Li Q, Gui H, Xu D-P, Yang Y-L, Su D-F, et al. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Res. 2013;23(11):1270\u201383.","journal-title":"Cell Res"},{"issue":"12","key":"1588_CR86","doi-asserted-by":"crossref","first-page":"e81774","DOI":"10.1371\/journal.pone.0081774","volume":"8","author":"T Veremeyko","year":"2013","unstructured":"Veremeyko T, Siddiqui S, Sotnikov I, Yung A, Ponomarev ED. IL-4\/IL-13-dependent and independent expression of miR-124 and Its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PLoS ONE. 2013;8(12):e81774.","journal-title":"PLoS ONE"},{"issue":"1","key":"1588_CR87","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm.2266","volume":"17","author":"ED Ponomarev","year":"2011","unstructured":"Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C\/EBP-\u03b1-PU.1 pathway. Nat Med. 2011;17(1):64\u201370.","journal-title":"Nat Med"},{"issue":"9","key":"1588_CR88","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.7150\/ijbs.59876","volume":"17","author":"P Jiao","year":"2021","unstructured":"Jiao P, Wang X-P, Luoreng Z-M, Yang J, Jia L, Ma Y, et al. miR-223: an effective regulator of immune cell differentiation and inflammation. Int J Biol Sci. 2021;17(9):2308\u201322.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"1588_CR89","doi-asserted-by":"crossref","first-page":"e37960","DOI":"10.1371\/journal.pone.0037960","volume":"7","author":"C-L Yang","year":"2012","unstructured":"Yang C-L, Liu Y-Y, Ma Y-G, Xue Y-X, Liu D-G, Ren Y, et al. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS ONE. 2012;7(5):e37960.","journal-title":"PLoS ONE"},{"issue":"1","key":"1588_CR90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yexcr.2018.03.004","volume":"366","author":"W Gou","year":"2018","unstructured":"Gou W, Zhang Z, Yang C, Li Y. MiR-223\/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization. Exp Cell Res. 2018;366(1):41\u20138.","journal-title":"Exp Cell Res"},{"issue":"27","key":"1588_CR91","doi-asserted-by":"crossref","first-page":"e2301243","DOI":"10.1002\/adhm.202301243","volume":"12","author":"N Ding","year":"2023","unstructured":"Ding N, Luo G, Li H, Xing C, Gao Y, Xi W, et al. A cyclodextrin-based pH-responsive MicroRNA delivery platform targeting polarization of M1 to M2 macrophages for sepsis therapy. Adv Healthc Mater. 2023;12(27):e2301243.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"1588_CR92","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01952204","volume":"44","author":"C Nissen","year":"1988","unstructured":"Nissen C, Gratwohl A, Tichelli A, Speck B. Abundant macrophage growth in culture from patients with chronic myelogenous leukemia: a risk factor for graft-versus-host disease after bone marrow transplantation. Experientia. 1988;44(2):167\u20139.","journal-title":"Experientia"},{"issue":"8","key":"1588_CR93","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/bmt.2015.114","volume":"50","author":"S Terakura","year":"2015","unstructured":"Terakura S, Martin PJ, Shulman HM, Storer BE. Cutaneous macrophage infiltration in acute GVHD. Bone Marrow Transpl. 2015;50(8):1135\u20137.","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"1588_CR94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cei.13043","volume":"190","author":"K Seno","year":"2017","unstructured":"Seno K, Yasunaga M, Kajiya H, Izaki-Hagio K, Morita H, Yoneda M, et al. Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft-versus-host disease in rats. Clin Exp Immunol. 2017;190(3):315\u201327.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"1588_CR95","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41409-019-0449-9","volume":"54","author":"Q Wen","year":"2019","unstructured":"Wen Q, Kong Y, Zhao H-Y, Zhang Y-Y, Han T-T, Wang Y, et al. G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2019;54(9):1419\u201333.","journal-title":"Bone Marrow Transpl"},{"issue":"11","key":"1588_CR96","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s11427-019-1691-x","volume":"63","author":"X Liu","year":"2020","unstructured":"Liu X, Su Y, Sun X, Fu H, Huang Q, Chen Q, et al. Arsenic trioxide alleviates acute graft-versus-host disease by modulating macrophage polarization. Sci China Life Sci. 2020;63(11):1744\u201354.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"1588_CR97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13045-022-01315-2","volume":"15","author":"Y Su","year":"2022","unstructured":"Su Y, Sun X, Liu X, Qu Q, Yang L, Chen Q, et al. hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype. J Hematol Oncol. 2022;15(1):99.","journal-title":"J Hematol Oncol"},{"issue":"14","key":"1588_CR98","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2009-03-209635","volume":"114","author":"S Nishiwaki","year":"2009","unstructured":"Nishiwaki S, Terakura S, Ito M, Goto T, Seto A, Watanabe K, et al. Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. Blood. 2009;114(14):3113\u20136.","journal-title":"Blood"},{"issue":"8","key":"1588_CR99","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2017.04.019","volume":"23","author":"Y Inamoto","year":"2017","unstructured":"Inamoto Y, Martin PJ, Paczesny S, Tabellini L, Momin AA, Mumaw CL, et al. Association of plasma CD163 concentration with De Novo-onset chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2017;23(8):1250\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"1588_CR100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","volume":"129","author":"KP MacDonald","year":"2017","unstructured":"MacDonald KP, Hill GR, Blazar BR. Chronic graft-versus-host disease: biological insights from preclinical and clinical studies. Blood. 2017;129(1):13\u201321.","journal-title":"Blood"},{"issue":"2","key":"1588_CR101","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1002\/mco2.147","volume":"3","author":"H Li","year":"2022","unstructured":"Li H, Wu M, Zhao X. Role of chemokine systems in cancer and inflammatory diseases. MedComm. 2022;3(2):e147.","journal-title":"MedComm"},{"key":"1588_CR102","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/B978-0-12-812630-1.00018-9","volume-title":"Immune biology of allogeneic hematopoietic stem cell transplantation","author":"KR Cooke","year":"2019","unstructured":"Cooke KR, Coghill JM, Serody JS. Chemokines and graft-versus-host disease. In: Immune biology of allogeneic hematopoietic stem cell transplantation. Elsevier; 2019. p. 323\u201347."},{"key":"1588_CR103","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MCHD-0028-2016","author":"H-H Lin","year":"2016","unstructured":"Lin H-H, Stacey M. G protein-coupled receptors in macrophages. Microbiol Spectr. 2016. https:\/\/doi.org\/10.1128\/microbiolspec.MCHD-0028-2016.","journal-title":"Microbiol Spectr"},{"key":"1588_CR104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.dci.2016.01.010","volume":"59","author":"GG Li","year":"2016","unstructured":"Li GG, Guo ZZ, Ma XF, Cao N, Geng SN, Zheng YQ, et al. The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis. Dev Comp Immunol. 2016;59:89\u201398.","journal-title":"Dev Comp Immunol"},{"issue":"4","key":"1588_CR105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bbrc.2012.08.126","volume":"426","author":"KA Cho","year":"2012","unstructured":"Cho KA, Woo SY, Park YS, Park MH, Ryu KH. Macrophage inflammatory protein-2 (MIP-2)\/CXCR2 blockade attenuates acute graft-versus-host disease while preserving graft-versus-leukemia activity. Biochem Biophys Res Commun. 2012;426(4):558\u201364.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"1588_CR106","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2005-05-1860","volume":"106","author":"TH Terwey","year":"2005","unstructured":"Terwey TH, Kim TD, Kochman AA, Hubbard VM, Lu S, Zakrzewski JL, et al. CCR2 is required for CD8-induced graft-versus-host disease. Blood. 2005;106(9):3322\u201330.","journal-title":"Blood"},{"issue":"15","key":"1588_CR107","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1182\/blood-2017-08-800623","volume":"131","author":"J Du","year":"2018","unstructured":"Du J, Flynn R, Paz K, Ren HG, Ogata Y, Zhang Q, et al. Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood. 2018;131(15):1743\u201354.","journal-title":"Blood"},{"issue":"18","key":"1588_CR108","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2017-01-758854","volume":"129","author":"J Du","year":"2017","unstructured":"Du J, Paz K, Flynn R, Vulic A, Robinson TM, Lineburg KE, et al. Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-\u03b2 production. Blood. 2017;129(18):2570\u201380.","journal-title":"Blood"},{"key":"1588_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.713631","author":"T Ara","year":"2021","unstructured":"Ara T, Hashimoto D. Novel insights into the mechanism of GVHD-induced tissue damage. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.713631.","journal-title":"Front Immunol"},{"issue":"5","key":"1588_CR110","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.immuni.2019.08.011","volume":"51","author":"M Koyama","year":"2019","unstructured":"Koyama M, Mukhopadhyay P, Schuster IS, Henden AS, H\u00fclsd\u00fcnker J, Varelias A, et al. MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota. Immunity. 2019;51(5):885-98.e7.","journal-title":"Immunity"},{"issue":"22","key":"1588_CR111","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR. Acute graft-versus-host disease\u2014biologic process, prevention, and therapy. N Engl J Med. 2017;377(22):2167\u201379.","journal-title":"N Engl J Med"},{"issue":"4","key":"1588_CR112","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood.2019003990","volume":"136","author":"K Wu","year":"2020","unstructured":"Wu K, Yuan Y, Yu H, Dai X, Wang S, Sun Z, et al. The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice. Blood. 2020;136(4):501\u201315.","journal-title":"Blood"},{"issue":"9","key":"1588_CR113","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1172\/JCI133909","volume":"130","author":"L Jardine","year":"2020","unstructured":"Jardine L, Cytlak U, Gunawan M, Reynolds G, Green K, Wang X-N, et al. Donor monocyte\u2014derived macrophages promote human acute graft-versus-host disease. J Clin Investig. 2020;130(9):4574\u201386.","journal-title":"J Clin Investig"},{"issue":"5","key":"1588_CR114","doi-asserted-by":"publisher","first-page":"248.e1","DOI":"10.1016\/j.jtct.2022.01.028","volume":"28","author":"AT Aasebo","year":"2022","unstructured":"Aasebo AT, Gedde-Dahl T, Reims HM, Baekkevold ES, Jahnsen FL. Calprotectin expressing donor-derived macrophages increase in acute gastrointestinal graft-versus-host disease. Transplant Cell Ther. 2022;28(5):248.e1-248.e8. https:\/\/doi.org\/10.1016\/j.jtct.2022.01.028.","journal-title":"Transplant Cell Ther"},{"key":"1588_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.614183","author":"C Hong","year":"2021","unstructured":"Hong C, Jin R, Dai X, Gao X. Functional contributions of antigen presenting cells in chronic graft-versus-host disease. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.614183.","journal-title":"Front Immunol"},{"key":"1588_CR116","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92111s","author":"E Forcade","year":"2017","unstructured":"Forcade E, Paz K, Flynn R, Griesenauer B, Amet T, Li W, Liu L, Bakoyannis G, Jiang Di, Chu HW, Lobera M, Yang J, Wilkes DS, Jing Du, Gartlan K, Hill GR, MacDonald KPA, Espada EL, Blanco P, Serody JS, Koreth J, Cutler CS, Antin JH, Soiffer RJ, Ritz J, Paczesny S, Blazar BR. An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition. JCI Insight. 2017. https:\/\/doi.org\/10.1172\/jci.insight.92111s.","journal-title":"JCI Insight"},{"issue":"3","key":"1588_CR117","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4049\/jimmunol.1400973","volume":"194","author":"S Okamoto","year":"2015","unstructured":"Okamoto S, Fujiwara H, Nishimori H, Matsuoka K, Fujii N, Kondo E, et al. Anti-IL-12\/23 p40 antibody attenuates experimental chronic graft-versus-host disease via suppression of IFN-\u03b3\/IL-17-producing cells. J Immunol. 2015;194(3):1357\u201363.","journal-title":"J Immunol"},{"issue":"5","key":"1588_CR118","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.4049\/jimmunol.1400954","volume":"193","author":"H Fujiwara","year":"2014","unstructured":"Fujiwara H, Maeda Y, Kobayashi K, Nishimori H, Matsuoka K, Fujii N, et al. Programmed death-1 pathway in host tissues ameliorates Th17\/Th1-mediated experimental chronic graft-versus-host disease. J Immunol. 2014;193(5):2565\u201373.","journal-title":"J Immunol"},{"issue":"10","key":"1588_CR119","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1172\/JCI75935","volume":"124","author":"KA Alexander","year":"2014","unstructured":"Alexander KA, Flynn R, Lineburg KE, Kuns RD, Teal BE, Olver SD, et al. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease. J Clin Investig. 2014;124(10):4266\u201380.","journal-title":"J Clin Investig"},{"key":"1588_CR120","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ebiom.2019.02.001","volume":"41","author":"R Ono","year":"2019","unstructured":"Ono R, Watanabe T, Kawakami E, Iwasaki M, Tomizawa-Murasawa M, Matsuda M, Najima Y, Takagi S, Fujiki S, Sato R, Mochizuki Y, Yoshida H, Sato K, Yabe H, Kato S, Saito Y, Taniguchi S, Shultz LD, Ohara O, Amagai M, Koseki H, Ishikawa F. Co-activation of macrophages and T cells contribute to chronic GVHD in human IL-6 transgenic humanised mouse model. EBioMedicine. 2019;41:584\u201396. https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.001.","journal-title":"EBioMedicine"},{"issue":"1","key":"1588_CR121","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm.2597","volume":"18","author":"M Koyama","year":"2011","unstructured":"Koyama M, Kuns RD, Olver SD, Raffelt NC, Wilson YA, Don AL, et al. Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease. Nat Med. 2011;18(1):135\u201342.","journal-title":"Nat Med"},{"issue":"2","key":"1588_CR122","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1189\/jlb.4RU0615-254RR","volume":"99","author":"L Zhang","year":"2016","unstructured":"Zhang L, Chu J, Yu J, Wei W. Cellular and molecular mechanisms in graft-versus-host disease. J Leukoc Biol. 2016;99(2):279\u201387.","journal-title":"J Leukoc Biol"},{"key":"1588_CR123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-102119-073227","volume":"39","author":"GR Hill","year":"2021","unstructured":"Hill GR, Betts BC, Tkachev V, Kean LS, Blazar BR. Current concepts and advances in graft-versus-host disease immunology. Annu Rev Immunol. 2021;39:19\u201349.","journal-title":"Annu Rev Immunol"},{"issue":"24","key":"1588_CR124","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1182\/blood.2019000823","volume":"134","author":"M Koyama","year":"2019","unstructured":"Koyama M, Hill GR. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease. Blood. 2019;134(24):2139\u201348.","journal-title":"Blood"},{"issue":"1","key":"1588_CR125","doi-asserted-by":"crossref","first-page":"15666","DOI":"10.1038\/s41598-017-15915-3","volume":"7","author":"K Hyv\u00e4rinen","year":"2017","unstructured":"Hyv\u00e4rinen K, Ritari J, Koskela S, Niittyvuopio R, Nihtinen A, Volin L, et al. Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease. Sci Rep. 2017;7(1):15666.","journal-title":"Sci Rep"},{"issue":"3","key":"1588_CR126","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/bjd\/ljad402","volume":"190","author":"J Strobl","year":"2023","unstructured":"Strobl J, Gail LM, Krecu L, Madad S, Kleissl L, Unterluggauer L, et al. Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease. Br J Dermatol. 2023;190(3):402\u201314.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1588_CR127","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/TP.0b013e3182985527","volume":"96","author":"J Tashiro-Yamaji","year":"2013","unstructured":"Tashiro-Yamaji J, Maeda S, Ikawa M, Okabe M, Kubota T, Yoshida R. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma. Transplantation. 2013;96(3):251\u20137.","journal-title":"Transplantation"},{"key":"1588_CR128","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125067","author":"BS Marro","year":"2019","unstructured":"Marro BS, Legrain S, Ware BC, Oldstone MBA. Macrophage IFN-I signaling promotes autoreactive T cell infiltration into islets in type 1 diabetes model. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.125067.","journal-title":"JCI Insight"},{"issue":"19","key":"1588_CR129","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1182\/blood-2014-12-615781","volume":"125","author":"H Uryu","year":"2015","unstructured":"Uryu H, Hashimoto D, Kato K, Hayase E, Matsuoka S, Ogasawara R, et al. \u03b1-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice. Blood. 2015;125(19):3014\u201323.","journal-title":"Blood"},{"issue":"6","key":"1588_CR130","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ajpath.2017.02.015","volume":"187","author":"B Sundarasetty","year":"2017","unstructured":"Sundarasetty B, Volk V, Theobald SJ, Rittinghausen S, Schaudien D, Neuhaus V, et al. Human effector memory T helper cells engage with mouse macrophages and cause graft-<em>versus<\/em>-host\u2013like pathology in skin of humanized mice used in a nonclinical immunization study. Am J Pathol. 2017;187(6):1380\u201398.","journal-title":"Am J Pathol"},{"issue":"2","key":"1588_CR131","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1084\/jem.20081633","volume":"206","author":"M Haniffa","year":"2009","unstructured":"Haniffa M, Ginhoux F, Wang X-N, Bigley V, Abel M, Dimmick I, et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J Exp Med. 2009;206(2):371\u201385.","journal-title":"J Exp Med"},{"issue":"3","key":"1588_CR132","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/cmi.2016.37","volume":"15","author":"Y Cai","year":"2018","unstructured":"Cai Y, Ma S, Liu Y, Gong H, Cheng Q, Hu B, et al. Adoptively transferred donor IL-17-producing CD4+ T cells augment, but IL-17 alleviates, acute graft-versus-host disease. Cell Mol Immunol. 2018;15(3):233\u201345.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"1588_CR133","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood-2015-12-684142","volume":"128","author":"BM Matta","year":"2016","unstructured":"Matta BM, Reichenbach DK, Zhang X, Mathews L, Koehn BH, Dwyer GK, et al. Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD. Blood. 2016;128(3):427\u201339.","journal-title":"Blood"},{"key":"1588_CR134","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.29540","author":"X Yuan","year":"2017","unstructured":"Yuan X, Yang B-H, Dong Yi, Yamamura A, Wenxian Fu. CRIg, a tissue-resident macrophage specific immune checkpoint molecule, promotes immunological tolerance in NOD mice, via a dual role in effector and regulatory T cells. Elife. 2017. https:\/\/doi.org\/10.7554\/eLife.29540.","journal-title":"Elife"},{"issue":"16","key":"1588_CR135","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood-2012-11-465658","volume":"121","author":"D Le Huu","year":"2013","unstructured":"Le Huu D, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, et al. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood. 2013;121(16):3274\u201383.","journal-title":"Blood"},{"issue":"1","key":"1588_CR136","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.transproceed.2005.01.025","volume":"37","author":"N Koyamada","year":"2005","unstructured":"Koyamada N, Sato A, Takayama J, Usuda M, Kawagishi N, Doi H, et al. Macrophage depletion prevents anti-graft antibody production and results in long-term survival in xenotransplantation. Transpl Proc. 2005;37(1):514\u20135.","journal-title":"Transpl Proc"},{"issue":"2","key":"1588_CR137","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.imlet.2005.11.006","volume":"103","author":"C Apicella","year":"2006","unstructured":"Apicella C, Custidiano A, Miranda S, Novoa L, Dokmetjian J, Gentile T. Differential macrophage modulation of asymmetric IgG antibody synthesis by soluble or particulate stimuli. Immunol Lett. 2006;103(2):177\u201385.","journal-title":"Immunol Lett"},{"key":"1588_CR138","first-page":"3538963","volume":"2019","author":"MCH Hogenes","year":"2019","unstructured":"Hogenes MCH, van Dorp S, van Kuik J, Monteiro FRP, Ter Hoeve N, Guedes L, et al. Modifying graft-versus-host disease in a humanized mouse model by targeting macrophages or B-cells. J Immunol Res. 2019;2019:3538963.","journal-title":"J Immunol Res"},{"key":"1588_CR139","doi-asserted-by":"crossref","first-page":"588449","DOI":"10.3389\/fphar.2020.588449","volume":"11","author":"R Kumari","year":"2020","unstructured":"Kumari R, Palaniyandi S, Hildebrandt GC. Metabolic reprogramming\u2014a new era how to prevent and treat graft versus host disease after allogeneic hematopoietic stem cell transplantation has begun. Front Pharmacol. 2020;11:588449.","journal-title":"Front Pharmacol"},{"key":"1588_CR140","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","volume":"10","author":"A Viola","year":"2019","unstructured":"Viola A, Munari F, S\u00e1nchez-Rodr\u00edguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Front Immunol. 2019;10:1462.","journal-title":"Front Immunol"},{"issue":"3","key":"1588_CR141","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"AK Jha","year":"2015","unstructured":"Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42(3):419\u201330.","journal-title":"Immunity"},{"issue":"1","key":"1588_CR142","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41467-020-14433-7","volume":"11","author":"EM Palmieri","year":"2020","unstructured":"Palmieri EM, Gonzalez-Cotto M, Baseler WA, Davies LC, Ghesqui\u00e8re B, Maio N, et al. Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat Commun. 2020;11(1):698.","journal-title":"Nat Commun"},{"issue":"10","key":"1588_CR143","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1541-7786.MCR-13-0682","volume":"12","author":"S Joshi","year":"2014","unstructured":"Joshi S, Singh AR, Zulcic M, Durden DL. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1\u03b1 and HIF2\u03b1 stability and tumor growth, angiogenesis, and metastasis. Mol Cancer Res. 2014;12(10):1520\u201331.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"1588_CR144","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","volume":"21","author":"EM Palsson-McDermott","year":"2015","unstructured":"Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MA, Sheedy FJ, Gleeson LE, et al. Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 2015;21(1):65\u201380.","journal-title":"Cell Metab"},{"issue":"3","key":"1588_CR145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.chom.2012.07.012","volume":"12","author":"E Qualls Joseph","year":"2012","unstructured":"Qualls Joseph E, Subramanian C, Rafi W, Smith Amber M, Balouzian L, DeFreitas AA, et al. Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1. Cell Host Microbe. 2012;12(3):313\u201323.","journal-title":"Cell Host Microbe"},{"issue":"11","key":"1588_CR146","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/metabo11110736","volume":"11","author":"K Mhandire","year":"2021","unstructured":"Mhandire K, Saggu K, Buxbaum NP. Immunometabolic therapeutic targets of graft-versus-host disease (GVHD). Metabolites. 2021;11(11):736.","journal-title":"Metabolites"},{"issue":"9","key":"1588_CR147","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"P-S Liu","year":"2017","unstructured":"Liu P-S, Wang H, Li X, Chao T, Teav T, Christen S, et al. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol. 2017;18(9):985\u201394.","journal-title":"Nat Immunol"},{"key":"1588_CR148","doi-asserted-by":"crossref","unstructured":"Holtan SG, Shabaneh A, Betts BC, Rashidi A, MacMillan ML, Ustun C, et al. Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease. JCI Insight. 2019;5(17).","DOI":"10.1172\/jci.insight.129762"},{"issue":"3","key":"1588_CR149","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/bjd\/ljad402","volume":"190","author":"J Strobl","year":"2024","unstructured":"Strobl J, Gail LM, Krecu L, Madad S, Kleissl L, Unterluggauer L, et al. Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease. Br J Dermatol. 2024;190(3):402\u201314.","journal-title":"Br J Dermatol"},{"key":"1588_CR150","doi-asserted-by":"crossref","first-page":"713631","DOI":"10.3389\/fimmu.2021.713631","volume":"12","author":"T Ara","year":"2021","unstructured":"Ara T, Hashimoto D. Novel insights into the mechanism of GVHD-induced tissue damage. Front Immunol. 2021;12:713631.","journal-title":"Front Immunol"},{"key":"1588_CR151","doi-asserted-by":"crossref","first-page":"2124627","DOI":"10.1155\/2022\/2124627","volume":"2022","author":"J Li","year":"2022","unstructured":"Li J, Zhang X, Chen Y, Zheng Q, Zhao M, Jiang H. A promising insight: the potential influence and therapeutic value of the gut microbiota in GI GVHD. Oxid Med Cell Longev. 2022;2022:2124627.","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"1588_CR152","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41374-021-00640-3","volume":"101","author":"J-M Liu","year":"2021","unstructured":"Liu J-M, Li M, Luo W, Sun H-B. Curcumin attenuates adriamycin-resistance of acute myeloid leukemia by inhibiting the lncRNA HOTAIR\/miR-20a-5p\/WT1 axis. Lab Invest. 2021;101(10):1308\u201317.","journal-title":"Lab Invest"},{"key":"1588_CR153","doi-asserted-by":"crossref","first-page":"779076","DOI":"10.3389\/fimmu.2021.779076","volume":"12","author":"A Rayasam","year":"2021","unstructured":"Rayasam A, Drobyski WR. Translational clinical strategies for the prevention of gastrointestinal tract graft versus host disease. Front Immunol. 2021;12:779076.","journal-title":"Front Immunol"},{"issue":"7","key":"1588_CR154","doi-asserted-by":"crossref","first-page":"110819","DOI":"10.1016\/j.celrep.2022.110819","volume":"39","author":"HC West","year":"2022","unstructured":"West HC, Davies J, Henderson S, Adegun OK, Ward S, Ferrer IR, et al. Loss of T cell tolerance in the skin following immunopathology is linked to failed restoration of the dermal niche by recruited macrophages. Cell Rep. 2022;39(7):110819.","journal-title":"Cell Rep"},{"issue":"7","key":"1588_CR155","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4049\/jimmunol.2200558","volume":"211","author":"H Zhang","year":"2023","unstructured":"Zhang H, Liu J, Sun Y, Huang J, Qi H, Shao R, et al. Nestin+ mesenchymal stromal cells fibrotic transition mediated by CD169+ macrophages in bone marrow chronic graft-versus-host disease. J Immunol. 2023;211(7):1154\u201366.","journal-title":"J Immunol"},{"issue":"12","key":"1588_CR156","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41409-018-0187-4","volume":"53","author":"T Konuma","year":"2018","unstructured":"Konuma T, Kohara C, Watanabe E, Mizukami M, Nagai E, Oiwa-Monna M, et al. Circulating monocyte subsets in human chronic graft-versus-host disease. Bone Marrow Transpl. 2018;53(12):1532\u201340.","journal-title":"Bone Marrow Transpl"},{"key":"1588_CR157","doi-asserted-by":"crossref","first-page":"614183","DOI":"10.3389\/fimmu.2021.614183","volume":"12","author":"C Hong","year":"2021","unstructured":"Hong C, Jin R, Dai X, Gao X. Functional contributions of antigen presenting cells in chronic graft-versus-host disease. Front Immunol. 2021;12:614183.","journal-title":"Front Immunol"},{"issue":"6","key":"1588_CR158","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2018.03.001","volume":"39","author":"KR Peterson","year":"2018","unstructured":"Peterson KR, Cottam MA, Kennedy AJ, Hasty AH. Macrophage-targeted therapeutics for metabolic disease. Trends Pharmacol Sci. 2018;39(6):536\u201346.","journal-title":"Trends Pharmacol Sci"},{"key":"1588_CR159","first-page":"651590","volume":"2013","author":"GE Pi\u00e9rard","year":"2013","unstructured":"Pi\u00e9rard GE, Hermanns-L\u00ea T, Paquet P, Rousseau AF, Delvenne P, Pi\u00e9rard-Franchimont C. Toxic epidermal necrolysis and graft-versus-host reaction: revisiting a puzzling similarity. ISRN Dermatol. 2013;2013:651590.","journal-title":"ISRN Dermatol"},{"issue":"20","key":"1588_CR160","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/bloodadvances.2018020321","volume":"2","author":"SA Wall","year":"2018","unstructured":"Wall SA, Zhao Q, Yearsley M, Blower L, Agyeman A, Ranganathan P, et al. Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD. Blood Adv. 2018;2(20):2619\u201328.","journal-title":"Blood Adv"},{"key":"1588_CR161","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3389\/fimmu.2018.02629","volume":"9","author":"D Argyle","year":"2018","unstructured":"Argyle D, Kitamura T. Targeting macrophage-recruiting chemokines as a novel therapeutic strategy to prevent the progression of solid tumors. Front Immunol. 2018;9:2629.","journal-title":"Front Immunol"},{"issue":"5","key":"1588_CR162","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2007.03.014","volume":"26","author":"MO Li","year":"2007","unstructured":"Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity. 2007;26(5):579\u201391.","journal-title":"Immunity"},{"issue":"3","key":"1588_CR163","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/cmi.2016.37","volume":"15","author":"Y Cai","year":"2018","unstructured":"Cai Y, Ma S, Liu Y, Gong H, Cheng Q, Hu B, et al. Adoptively transferred donor IL-17-producing CD4(+) T cells augment, but IL-17 alleviates, acute graft-versus-host disease. Cell Mol Immunol. 2018;15(3):233\u201345.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1588_CR164","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s42003-023-05552-0","volume":"6","author":"A Zanin-Zhorov","year":"2023","unstructured":"Zanin-Zhorov A, Chen W, Moretti J, Nyuydzefe MS, Zhorov I, Munshi R, et al. Selectivity matters: selective ROCK2 inhibitor ameliorates established liver fibrosis via targeting inflammation, fibrosis, and metabolism. Commun Biol. 2023;6(1):1176.","journal-title":"Commun Biol"},{"issue":"17","key":"1588_CR165","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood-2015-10-678706","volume":"127","author":"R Flynn","year":"2016","unstructured":"Flynn R, Paz K, Du J, Reichenbach DK, Taylor PA, Panoskaltsis-Mortari A, et al. Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. Blood. 2016;127(17):2144\u201354.","journal-title":"Blood"},{"issue":"3","key":"1588_CR166","first-page":"427","volume":"128","author":"BM Matta","year":"2016","unstructured":"Matta BM, Reichenbach DK. Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD. J Am Soc Hematol. 2016;128(3):427\u201339.","journal-title":"J Am Soc Hematol"},{"key":"1588_CR167","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cellimm.2016.05.004","volume":"306\u2013307","author":"MA Wood","year":"2016","unstructured":"Wood MA, Goldman N, DePierri K, Somerville J, Riggs JE. Erythropoietin increases macrophage-mediated T cell suppression. Cell Immunol. 2016;306\u2013307:17\u201324.","journal-title":"Cell Immunol"},{"issue":"9","key":"1588_CR168","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.jid.2017.02.986","volume":"137","author":"JY Lim","year":"2017","unstructured":"Lim JY, Ryu DB, Lee SE, Park G, Min CK. Mesenchymal stem cells (MSCs) attenuate cutaneous sclerodermatous graft-versus-host disease (Scl-GVHD) through inhibition of immune cell infiltration in a mouse model. J Invest Dermatol. 2017;137(9):1895\u2013904.","journal-title":"J Invest Dermatol"},{"key":"1588_CR169","doi-asserted-by":"crossref","first-page":"41939","DOI":"10.1038\/srep41939","volume":"7","author":"S Mukai","year":"2017","unstructured":"Mukai S, Ogawa Y, Urano F, Kudo-Saito C, Kawakami Y, Tsubota K. Novel treatment of chronic graft-versus-host disease in mice using the ER stress reducer 4-phenylbutyric acid. Sci Rep. 2017;7:41939.","journal-title":"Sci Rep"},{"issue":"15","key":"1588_CR170","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1182\/blood-2017-08-800623","volume":"131","author":"Du Jing","year":"2018","unstructured":"Jing Du, Flynn R, Paz K, Ren H-G, Ogata Y, Zhang Q, Gafken PR, Storer BE, Roy NH, Burkhardt JK, Mathews W, Tolar J, Lee SJ, Blazar BR, Paczesny S. Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood. 2018;131(15):1743\u201354. https:\/\/doi.org\/10.1182\/blood-2017-08-800623.","journal-title":"Blood"},{"issue":"7","key":"1588_CR171","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.7150\/thno.29682","volume":"9","author":"S Du","year":"2019","unstructured":"Du S, Li C, Lu Y, Lei X, Zhang Y, Li S, et al. Dioscin alleviates crystalline silica-induced pulmonary inflammation and fibrosis through promoting alveolar macrophage autophagy. Theranostics. 2019;9(7):1878\u201392.","journal-title":"Theranostics"},{"issue":"5","key":"1588_CR172","doi-asserted-by":"crossref","first-page":"539","DOI":"10.17219\/acem\/155373","volume":"32","author":"P \u0141acina","year":"2023","unstructured":"\u0141acina P, Crossland RE, Wieli\u0144ska J, Czy\u017c A, Szeremet A, Ussowicz M, et al. Differential expression of miRNAs from extracellular vesicles in chronic graft-versus-host disease: a preliminary study. Adv Clin Exp Med. 2023;32(5):539\u201344.","journal-title":"Adv Clin Exp Med"},{"key":"1588_CR173","doi-asserted-by":"crossref","unstructured":"Chung S, Overstreet JM, Li Y, Wang Y, Niu A, Wang S, et al. TGF-\u03b2 promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration. JCI Insight. 2018;3(21).","DOI":"10.1172\/jci.insight.123563"},{"key":"1588_CR174","doi-asserted-by":"crossref","first-page":"109237","DOI":"10.1016\/j.clim.2023.109237","volume":"248","author":"F Mahmoudi","year":"2023","unstructured":"Mahmoudi F, Hanachi P, Montaseri A. Extracellular vesicles of immune cells; immunomodulatory impacts and therapeutic potentials. Clin Immunol. 2023;248:109237.","journal-title":"Clin Immunol"},{"issue":"3","key":"1588_CR175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/leu.2017.277","volume":"32","author":"G Lia","year":"2018","unstructured":"Lia G, Brunello L, Bruno S, Carpanetto A, Omed\u00e8 P, Festuccia M, et al. Extracellular vesicles as potential biomarkers of acute graft-vs-host disease. Leukemia. 2018;32(3):765\u201373.","journal-title":"Leukemia"},{"issue":"9","key":"1588_CR176","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1172\/JCI133909","volume":"130","author":"L Jardine","year":"2020","unstructured":"Jardine L, Cytlak U, Gunawan M, Reynolds G, Green K, Wang XN, et al. Donor monocyte-derived macrophages promote human acute graft-versus-host disease. J Clin Investig. 2020;130(9):4574\u201386.","journal-title":"J Clin Investig"},{"issue":"6","key":"1588_CR177","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/blood-2011-08-374793","volume":"121","author":"N Ismail","year":"2013","unstructured":"Ismail N, Wang Y, Dakhlallah D, Moldovan L, Agarwal K, Batte K, et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 2013;121(6):984\u201395.","journal-title":"Blood"},{"key":"1588_CR178","unstructured":"Nakamachi Y, Saegusa J, Kawano S. MicroRNA-124: a promising therapeutic agent for various human diseases, including rheumatoid arthritis. RNA & DISEASE. 2017;4."},{"issue":"1","key":"1588_CR179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1882927","volume":"13","author":"F Hosseinkhani","year":"2021","unstructured":"Hosseinkhani F, Heinken A, Thiele I, Lindenburg PW, Harms AC, Hankemeier T. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut microbes. 2021;13(1):1\u201322.","journal-title":"Gut microbes"},{"issue":"5","key":"1588_CR180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrc.2018.10","volume":"18","author":"Y Shono","year":"2018","unstructured":"Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer. 2018;18(5):283\u201395.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1588_CR181","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020\u201332.","journal-title":"Gut"},{"issue":"1","key":"1588_CR182","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55\u201371.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"1588_CR183","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41385-022-00527-6","volume":"15","author":"SA Jansen","year":"2022","unstructured":"Jansen SA, Nieuwenhuis EES, Hanash AM, Lindemans CA. Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease. Mucosal Immunol. 2022;15(4):605\u201319.","journal-title":"Mucosal Immunol"},{"key":"1588_CR184","doi-asserted-by":"crossref","first-page":"703298","DOI":"10.3389\/fimmu.2021.703298","volume":"12","author":"H Fujiwara","year":"2021","unstructured":"Fujiwara H. Crosstalk between intestinal microbiota derived metabolites and tissues in allogeneic hematopoietic cell transplantation. Front Immunol. 2021;12:703298.","journal-title":"Front Immunol"},{"key":"1588_CR185","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3389\/fimmu.2018.00669","volume":"9","author":"L Han","year":"2018","unstructured":"Han L, Jin H, Zhou L, Zhang X, Fan Z, Dai M, et al. Intestinal microbiota at engraftment influence acute graft-versus-host disease via the Treg\/Th17 balance in Allo-HSCT recipients. Front Immunol. 2018;9:669.","journal-title":"Front Immunol"},{"key":"1588_CR186","doi-asserted-by":"crossref","first-page":"813576","DOI":"10.3389\/fmicb.2022.813576","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Huang L, Huang T, Geng S, Chen X, Huang X, et al. The gut bacteria dysbiosis contributes to chronic graft-versus-host disease associated with a Treg\/Th1 ratio imbalance. Front Microbiol. 2022;13:813576.","journal-title":"Front Microbiol"},{"issue":"2","key":"1588_CR187","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","volume":"23","author":"KR Cooke","year":"2017","unstructured":"Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, et al. The biology of chronic graft-versus-host disease: a task force report from the national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2017;23(2):211\u201334.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1588_CR188","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","volume":"27","author":"FO Martinez","year":"2009","unstructured":"Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451\u201383.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"1588_CR189","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s13340-016-0290-y","volume":"7","author":"S Fujisaka","year":"2016","unstructured":"Fujisaka S, Usui I, Nawaz A, Takikawa A, Kado T, Igarashi Y, et al. M2 macrophages in metabolism. Diabetol Int. 2016;7(4):342\u201351.","journal-title":"Diabetol Int"},{"issue":"3","key":"1588_CR190","doi-asserted-by":"crossref","first-page":"e1433","DOI":"10.1002\/term.2560","volume":"12","author":"HR Caires","year":"2018","unstructured":"Caires HR, Barros da Silva P, Barbosa MA, Almeida CR. A co-culture system with three different primary human cell populations reveals that biomaterials and MSC modulate macrophage-driven fibroblast recruitment. J Tissue Eng Regen Med. 2018;12(3):e1433\u201340.","journal-title":"J Tissue Eng Regen Med"},{"issue":"7","key":"1588_CR191","doi-asserted-by":"crossref","first-page":"F52","DOI":"10.1152\/ajprenal.00260.2018","volume":"317","author":"E Ueshima","year":"2019","unstructured":"Ueshima E, Fujimori M, Kodama H, Felsen D, Chen J, Durack JC, et al. Macrophage-secreted TGF-\u03b2(1) contributes to fibroblast activation and ureteral stricture after ablation injury. Am J Physiol Renal Physiol. 2019;317(7):F52-f64.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1588_CR192","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.7150\/ijbs.33710","volume":"15","author":"M Wang","year":"2019","unstructured":"Wang M, Jiang S, Zhou L, Yu F, Ding H, Li P, et al. Potential mechanisms of action of curcumin for cancer prevention: focus on cellular signaling pathways and miRNAs. Int J Biol Sci. 2019;15(6):1200.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"1588_CR193","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/cmi.2014.59","volume":"12","author":"Q Cheng","year":"2015","unstructured":"Cheng Q, Ma S, Lin D, Mei Y, Gong H, Lei L, et al. The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment. Cell Mol Immunol. 2015;12(6):681\u201391.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1588_CR194","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12974-023-02984-7","volume":"20","author":"SN Shaikh","year":"2023","unstructured":"Shaikh SN, Willis EF, Dierich M, Xu Y, Stuart SJS, Gobe GC, et al. CSF-1R inhibitor PLX3397 attenuates peripheral and brain chronic GVHD and improves functional outcomes in mice. J Neuroinflammation. 2023;20(1):300.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"1588_CR195","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.22.00958","volume":"41","author":"CL Kitko","year":"2023","unstructured":"Kitko CL, Arora M, DeFilipp Z, Zaid MA, Stasi AD, Radojcic V, et al. Axatilimab for chronic graft-versus-host disease after failure of at least two prior systemic therapies: results of a phase I\/II study. J Clin Oncol. 2023;41(10):1864\u201375.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1588_CR196","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa2401537","volume":"391","author":"D Wolff","year":"2024","unstructured":"Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, et al. Axatilimab in recurrent or refractory chronic graft-versus-host disease. N Engl J Med. 2024;391(11):1002\u201314.","journal-title":"N Engl J Med"},{"issue":"1","key":"1588_CR197","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2040620717741860","volume":"9","author":"L Hill","year":"2018","unstructured":"Hill L, Alousi A, Kebriaei P, Mehta R, Rezvani K, Shpall E. New and emerging therapies for acute and chronic graft versus host disease. Ther Adv Hematol. 2018;9(1):21\u201346.","journal-title":"Ther Adv Hematol"},{"issue":"6","key":"1588_CR198","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/mp100253e","volume":"7","author":"W Gao","year":"2010","unstructured":"Gao W, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Mol Pharm. 2010;7(6):1913\u201320.","journal-title":"Mol Pharm"},{"issue":"5","key":"1588_CR199","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1039\/C3PY01192E","volume":"5","author":"M Huo","year":"2014","unstructured":"Huo M, Yuan J, Tao L, Wei Y. Redox-responsive polymers for drug delivery: from molecular design to applications. Polym Chem. 2014;5(5):1519\u201328.","journal-title":"Polym Chem"},{"issue":"10","key":"1588_CR200","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s43032-024-01676-8","volume":"31","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Ahangarpour A, Rajaei E, Sharifani MS, Aghaei M. Meta-analytical and meta-regression evaluation of subclinical hyperthyroidism\u2019s effect on male reproductive health: hormonal and seminal perspectives. Reprod Sci. 2024;31(10):2957\u201371.","journal-title":"Reprod Sci"},{"issue":"2","key":"1588_CR201","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","volume":"148","author":"F Danhier","year":"2010","unstructured":"Danhier F, Feron O, Pr\u00e9at V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148(2):135\u201346.","journal-title":"J Control Release"},{"issue":"6","key":"1588_CR202","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/bm400234c","volume":"14","author":"Y Shi","year":"2013","unstructured":"Shi Y, van Steenbergen MJ, Teunissen EA, Novo L, Gradmann S, Baldus M, et al. \u03a0-\u03c0 stacking increases the stability and loading capacity of thermosensitive polymeric micelles for chemotherapeutic drugs. Biomacromol. 2013;14(6):1826\u201337.","journal-title":"Biomacromol"},{"issue":"9","key":"1588_CR203","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.7150\/thno.14858","volume":"6","author":"D Liu","year":"2016","unstructured":"Liu D, Yang F, Xiong F, Gu N. The smart drug delivery system and its clinical potential. Theranostics. 2016;6(9):1306\u201323.","journal-title":"Theranostics"},{"key":"1588_CR204","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2147\/IJN.S298159","volume":"16","author":"T Liang","year":"2021","unstructured":"Liang T, Zhang R, Liu X, Ding Q, Wu S, Li C, et al. Recent advances in macrophage-mediated drug delivery systems. Int J Nanomed. 2021;16:2703\u201314.","journal-title":"Int J Nanomed"},{"issue":"5","key":"1588_CR205","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acs.molpharmaceut.2c00929","volume":"20","author":"P Ning","year":"2023","unstructured":"Ning P, Yao H, Du F, Yuan J, Xia Y, Yang P, et al. Gene reprogramming armed macrophage membrane-camouflaged nanoplatform enhances bionic targeted drug delivery to solid tumor for synergistic therapy. Mol Pharm. 2023;20(5):2362\u201375.","journal-title":"Mol Pharm"},{"issue":"4","key":"1588_CR206","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MOT.0000000000000219","volume":"20","author":"EF Reed","year":"2015","unstructured":"Reed EF. Technical and conceptual advances in histocompatibility and immunogenetics inform on mechanisms of transplant rejection and pave the way to development of novel therapies. Curr Opin Organ Transpl. 2015;20(4):444\u20135.","journal-title":"Curr Opin Organ Transpl"},{"issue":"9","key":"1588_CR207","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/s12276-023-01068-z","volume":"55","author":"YR Na","year":"2023","unstructured":"Na YR, Kim SW, Seok SH. A new era of macrophage-based cell therapy. Exp Mol Med. 2023;55(9):1945\u201354.","journal-title":"Exp Mol Med"},{"key":"1588_CR208","doi-asserted-by":"crossref","first-page":"155794","DOI":"10.1016\/j.phymed.2024.155794","volume":"131","author":"H Liu","year":"2024","unstructured":"Liu H, Huang M, Xin D, Wang H, Yu H, Pu W. Natural products with anti-tumorigenesis potential targeting macrophage. Phytomedicine. 2024;131:155794.","journal-title":"Phytomedicine"},{"key":"1588_CR209","unstructured":"Shi B, Du M, Chen Z. Advances in tumor immunotherapy targeting macrophages. Expert Rev Clin Immunol. 2024:1\u201318."},{"issue":"2","key":"1588_CR210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s13402-023-00881-y","volume":"47","author":"L Li","year":"2024","unstructured":"Li L, Ma S-R, Yu Z-L. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: a novel insight into cancer immunotherapy. Cell Oncol. 2024;47(2):415\u201328.","journal-title":"Cell Oncol"},{"key":"1588_CR211","first-page":"35","volume":"1","author":"T Malachowski","year":"2020","unstructured":"Malachowski T, Hassel A. Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery. Eng Regen. 2020;1:35\u201350.","journal-title":"Eng Regen"},{"key":"1588_CR212","doi-asserted-by":"crossref","first-page":"1324396","DOI":"10.3389\/fbioe.2023.1324396","volume":"11","author":"T Zaplana","year":"2023","unstructured":"Zaplana T, Miele S, Tolonen AC. Lachnospiraceae are emerging industrial biocatalysts and biotherapeutics. Front Bioeng Biotechnol. 2023;11:1324396.","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"1588_CR213","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/bloodadvances.2020001531","volume":"4","author":"M Payen","year":"2020","unstructured":"Payen M, Nicolis I, Robin M, Michonneau D, Delannoye J, Mayeur C, et al. Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity. Blood Adv. 2020;4(9):1824\u201332.","journal-title":"Blood Adv"},{"key":"1588_CR214","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3389\/fmicb.2020.01642","volume":"11","author":"CA Devaux","year":"2020","unstructured":"Devaux CA, Million M, Raoult D. The Butyrogenic and lactic bacteria of the gut microbiota determine the outcome of allogenic hematopoietic cell transplant. Front Microbiol. 2020;11:1642.","journal-title":"Front Microbiol"},{"issue":"1","key":"1588_CR215","first-page":"6666114","volume":"2021","author":"X He","year":"2021","unstructured":"He X, Zhao S, Li Y. Faecalibacterium prausnitzii: a next-generation probiotic in gut disease improvement. Can J Infect Dis Med Microbiol. 2021;2021(1):6666114.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"1588_CR216","doi-asserted-by":"crossref","unstructured":"Danne C, Creusot L, de Oliveira Formiga R, Marquet F, Sedda D, Hua L, et al.; induces an anti-inflammatory response and a metabolic reprogramming in human monocytes. bioRxiv. 2024:2024.10.06.616495.","DOI":"10.1101\/2024.10.06.616495"},{"key":"1588_CR217","doi-asserted-by":"crossref","unstructured":"Pan Y, Zhao X, Chen Q, Zhao T, Ma Y, Wu H, Xiang Y, Jiang P, Li W, Yan Q, Mao S. Faecalibacterium Prausnitzii Extracellular Vesicles Regulating Macrophage Differentiation via Homologous Recombination Repair in Inflammatory Bowel Disease. 2024.","DOI":"10.21203\/rs.3.rs-5368938\/v1"},{"key":"1588_CR218","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1182\/asheducation-2015.1.225","volume":"2015","author":"RS Negrin","year":"2015","unstructured":"Negrin RS. Graft-versus-host disease versus graft-versus-leukemia. Hematol Am Soc Hematol Educ Program. 2015;2015:225\u201330.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"9","key":"1588_CR219","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1097\/TP.0000000000004697","volume":"107","author":"A Al Jurdi","year":"2023","unstructured":"Al Jurdi A, Morena L, Verhoeff R, Alzahrani N, Kotton CN, Riella LV. Tixagevimab-cilgavimab preexposure prophylaxis in solid organ transplant recipients is associated with fewer breakthrough SARS-CoV-2 infections, except during the BA.5 period. Transplantation. 2023;107(9):e238\u201340.","journal-title":"Transplantation"},{"issue":"11","key":"1588_CR220","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/ijms25115789","volume":"25","author":"E Gavriilaki","year":"2024","unstructured":"Gavriilaki E, Christoforidi M, Ouranos K, Minti F, Mallouri D, Varelas C, et al. Alteration of gut microbiota composition and diversity in acute and\/or chronic graft-versus-host disease following hematopoietic stem cell transplantation: a prospective cohort study. Int J Mol Sci. 2024;25(11):5789.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1588_CR221","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s40168-021-01100-2","volume":"9","author":"AC Ingham","year":"2021","unstructured":"Ingham AC, Kielsen K, Mordhorst H, Ifversen M, Aarestrup FM, M\u00fcller KG, et al. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Microbiome. 2021;9(1):148.","journal-title":"Microbiome"},{"issue":"7","key":"1588_CR222","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/jnr.24229","volume":"96","author":"A Gautam","year":"2018","unstructured":"Gautam A, Kumar R, Chakraborty N, Muhie S, Hoke A, Hammamieh R, et al. Altered fecal microbiota composition in all male aggressor-exposed rodent model simulating features of post-traumatic stress disorder. J Neurosci Res. 2018;96(7):1311\u201323.","journal-title":"J Neurosci Res"},{"issue":"1","key":"1588_CR223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","volume":"13","author":"A Nogal","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut microbes. 2021;13(1):1\u201324.","journal-title":"Gut microbes"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01588-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T16:02:47Z","timestamp":1764950567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01588-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":223,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1588"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01588-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"73"}}